Literature DB >> 23727296

Chronic obstructive pulmonary disease and cardiovascular disease.

Surya P Bhatt1, Mark T Dransfield.   

Abstract

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease of the lung associated with progressive airflow limitation and punctuated by episodes of acute exacerbation. There is growing recognition that the inflammatory state associated with COPD is not confined to the lungs but also involves the systemic circulation and can impact nonpulmonary organs. Epidemiologic and mechanistic studies indicate that COPD is associated with a high frequency of coronary artery disease, congestive heart failure and cardiac arrhythmias, independent of shared risk factors. Possible pathways include complex interrelationships between chronic low-grade systemic inflammation and oxidative stress as well as shared risk factors such as age, cigarette smoking, and environmental pollutants. In this review, we provide an overview of the epidemiologic data linking COPD with cardiovascular disease, comment on the interrelationships among COPD, inflammation, and cardiovascular disease, and highlight diagnostic and therapeutic challenges.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  C-reactive protein; CAD; CHF; CI; COPD; CRP; CT; CVD; FEV1; FVC; HR; IL; IMT; OR; PM; PVD; RAS; RR; cardiovascular disease; chronic obstructive pulmonary disease; computed tomography; confidence interval; congestive heart failure; coronary artery disease; force vital capacity; forced expiratory volume in the first second; hazard ratio; high sensitivity; hs; interleukin; intima medial thickness; odds ratio; particulate matter; peripheral vascular disease; relative risk; renin angiotensin system

Mesh:

Year:  2013        PMID: 23727296     DOI: 10.1016/j.trsl.2013.05.001

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  66 in total

1.  Cardiac Morphometry on Computed Tomography and Exacerbation Reduction with β-Blocker Therapy in Chronic Obstructive Pulmonary Disease.

Authors:  Surya P Bhatt; Gonzalo Vegas-Sánchez-Ferrero; Farbod N Rahaghi; Erick S MacLean; German Gonzalez-Serrano; Carolyn E Come; Gregory L Kinney; John E Hokanson; Matthew J Budoff; Michael J Cuttica; J Michael Wells; Raúl San José Estépar; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

2.  Hidden in Plain Sight: Lung Impairment in Ischemic Heart Disease.

Authors:  Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2016-09-01       Impact factor: 21.405

Review 3.  Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.

Authors:  Vasiliki Petta; Fotis Perlikos; Stelios Loukides; Petros Bakakos; Athanasios Chalkias; Nicoletta Iacovidou; Theodoros Xanthos; Dorothea Tsekoura; Georgios Hillas
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

4.  Diagnosis of Chronic Obstructive Pulmonary Disease: Breathing New Life into an Old Debate.

Authors:  Surya P Bhatt
Journal:  Ann Am Thorac Soc       Date:  2018-02

5.  Prodromal clinical, demographic, and socio-ecological correlates of asthma in adults: a 10-year statewide big data multi-domain analysis.

Authors:  Jennifer N Fishe; Jiang Bian; Zhaoyi Chen; Hui Hu; Jae Min; Francois Modave; Mattia Prosperi
Journal:  J Asthma       Date:  2019-07-26       Impact factor: 2.515

6.  Impact of reduced forced expiratory volume on cardiac prognosis in patients with chronic heart failure.

Authors:  Yuki Honda; Tetsu Watanabe; Yoichiro Otaki; Harutoshi Tamura; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Tetsuro Shishido; Takuya Miyamoto; Yoko Shibata; Isao Kubota
Journal:  Heart Vessels       Date:  2018-03-19       Impact factor: 2.037

7.  Airflow obstruction, atherosclerosis and cardiovascular risk factors in the AGES Reykjavik study.

Authors:  Gunnar Gudmundsson; Olof Birna Margretardottir; Martin Ingi Sigurdsson; Tamara B Harris; Lenore J Launer; Sigurdur Sigurdsson; Orn Olafsson; Thor Aspelund; Vilmundur Gudnason
Journal:  Atherosclerosis       Date:  2016-07-28       Impact factor: 5.162

8.  Disparate Rates of Utilization and Progression to Combined Heart Failure and Chronic Obstructive Pulmonary Disease among Asians and Pacific Islanders in Hawai'i.

Authors:  James Davis; Elizabeth Tam; Deborah Taira
Journal:  Hawaii J Med Public Health       Date:  2016-08

9.  β-Blockers are associated with a reduction in COPD exacerbations.

Authors:  Surya P Bhatt; James M Wells; Gregory L Kinney; George R Washko; Matthew Budoff; Young-Il Kim; William C Bailey; Hrudaya Nath; John E Hokanson; Edwin K Silverman; James Crapo; Mark T Dransfield
Journal:  Thorax       Date:  2015-08-17       Impact factor: 9.139

10.  Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Anand S Iyer; Surya P Bhatt; Jeffrey J Garner; J Michael Wells; Jennifer L Trevor; Neha M Patel; deNay Kirkpatrick; John C Williams; Mark T Dransfield
Journal:  Ann Am Thorac Soc       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.